We are a team of dedicated scientists striving to advance treatments in multiple indications in our cell therapy platform. Our mission is to utilize the power of genetics to deliver life-transformative cell therapies by unlocking the potential of engineered cellular medicine.
Location: United States, Maryland, Baltimore
Employees: 11-50
Total raised: $63M
Investors 4
| Date | Name | Website |
| - | Early Ligh... | earlylight... |
| - | TEDCO | tedcomd.co... |
| - | Johns Hopk... | ventures.j... |
| - | Riptide Ve... | riptide.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.10.2022 | Series B | $31M | - |
| 23.06.2021 | Series A | $32M | - |
Mentions in press and media 12
| Date | Title | Description |
| 12.01.2023 | Baltimore closed 2022 with an uptick in investment. But the tally may be incomplete | Editor’s note: These figures may vary slightly, as some deals aren’t accounted for until weeks after quarterly VC reports are published. If a reported drop in VC activity between 2022’s second and third quarters suggested that Baltimore was... |
| 17.10.2022 | Vita Therapeutics Closes $31M Series B Financing | Vita Therapeutics, a Baltimore, MD-based cell engineering company, raised $31M in Series B funding. The round was led by Cambrian BioPharma, and Solve FSHD, with participation from Riptide Ventures, Cedars Sinai, and TEDCO. The company, whi... |
| 13.10.2022 | CORRECTION -- SOLVE FSHD invests US$10 Million in Vita Therapeutics | VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- In a release issued today by SOLVE FSHD under the same headline, please note that the embedded link for Vita Therapeutics in paragraph one has been updated. The corrected releas... |
| 13.10.2022 | SOLVE FSHD invests US$10 Million in Vita Therapeutics | VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- SOLVE FSHD, a venture-philanthropic organization catalyzing the pace of innovation to accelerate a cure for facioscapulohumeral muscular dystrophy (FSHD), announced today an inv... |
| 12.10.2022 | Vita Therapeutics Closes $31M Series B Financing. | BALTIMORE, MD, Vita Therapeutics, a cell engineering company, announced the completion of a $31 million Series B financing. >> Click here for more funding data on Vita Therapeutics >> To export Vita Therapeutics funding data... |
| 12.10.2022 | Vita Therapeutics Closes $31 Million Series B Financing | BALTIMORE, MD, Vita Therapeutics, a cell engineering company, announced the completion of a $31 million Series B financing. >> Click here for more funding data on Vita Therapeutics >> To export Vita Therapeutics funding data... |
| 08.09.2022 | 3 takeaways from Johns Hopkins Technology Ventures’ annual report | Johns Hopkins University is offering a by-the-numbers look into its entrepreneurship ecosystem with the recent release of Johns Hopkins Technology Ventures’ (JHTV) annual report. JHTV works with faculty and students to bring discoveries fro... |
| 25.06.2021 | Vita Therapeutics Raises $32M in Series A Financing | Vita Therapeutics, a Baltimore, Md.-based cell engineering company harnessing the power of genetics to develop cellular therapies that follow an autologous and universal hypoimmunogenic approach, raised $32m in Series A funding. The round w... |
| 23.06.2021 | Money Moves: It’s a big investment week for Frederick companies | This week, a pair of Frederick companies raised millions in new investment, offering evidence of the Maryland city’s growing role as one of the region’s tech hubs. Check out the specifics on those companies and more:Vita Therapeutics raised... |
| 18.11.2020 | Maryland is eyeing these 20 startups for future success | Tuesday was National Entrepreneur’s Day, and Gov. Larry Hogan of Maryland used the occasion to announce his list of 20 promising startups across the state. The Maryland Future 20, released by the Maryland Department of Commerce, aims to hig... |
Show more